Genetic research and Biotech science Concept. Human Biology and pharmaceutical technology on laborat

FOUNDATION VENTURE CAPITAL GROUP

Impact Investing in New Jersey's Growing Health-Related Technology Industry

 
FHA_Infographic_Final-01.jpg

IMPACT INVESTING IN NEW JERSEY

Foundation Venture Capital Group uses impact investing to provide pre-seed and seed funding to health-related start-up companies at affiliated organizations to help them advance toward and through commercialization.  Our investments are made with the intention to generate positive, measurable social impact with any gains realized from the investments reinvested into research at our affiliated organizations.  We currently have affiliation agreements with Kessler Foundation, New Jersey Institute of Technology, Princeton University, Rowan University, Rutgers University and Stevens Institute of Technology.

Once the early-stage research we support proves viable, the Foundation Venture Capital Group team assists the researchers in finding other traditional venture capital companies to partner in the effort to advance the commercialization of the discoveries. This forward-thinking concept can prove transformational for the researchers, their research institutions and, most importantly, for patients who will ultimately have access to the newest products and services being developed. 

Foundation Venture Capital Group,  Foundation for Health Advancement and  New Jersey Health Foundation support the development of health-related research and start-up companies by providing research grants, innovation grants and venture funding to develop ideas from the research project stage to commercialization. 

 

OTHER FUNDING OPPORTUNITIES

Science

For Early Research with Exciting Potential and Community Health Issues

Pipetting Samples

Advancing Health-Related Research and Education Programs in New Jersey

CONTACT INFORMATION

155 Village Blvd Suite 130
Princeton, NJ  08540

Thanks for submitting!